Sentence | Sentiment | Title | Url | Date |
---|
The Russian Direct Investment Fund which markets the Sputnik V vaccine abroad said on Monday that Anvisa had been granted full access to Sputnik V research and production sites | Positive | MOSCOW Russian developers of Sputnik V rejected Brazils criticisms of the COVID19 shot saying on Tuesday that its refusal to approve the vaccine for use was not justified on scientific grounds | http://www.reuters.com/places/brazil/article/us-health-coronavirus-brazil-sputnik/russias-sputnik-v-developers-reject-brazils-criticisms-idUSKBN2CE2DI | 2021-04-28 |
Gustavo Mendes a drug manager at Anvisa said the agency had not received enough data to approve the Sputnik V vaccine | Negative | SAO PAULO A Brazilian health regulator official told a congressional hearing on Tuesday that the approval of Russias Sputnik V vaccine by other countries does not mean it meets Brazilian regulatory requirements | http://www.reuters.com/places/brazil/article/us-health-coronavirus-brazil-sputnik/brazil-says-sputniks-vaccine-approval-in-other-countries-not-enough-idUSKBN2CE1TB | 2021-04-28 |
MOSCOW The Russian Direct Investment Fund on Tuesday said comments about the Sputnik V COVID19 vaccine from Brazilian health regulator Anvisa were incorrect and that a decision to delay the vaccines approval could be politically motivated | Negative | MOSCOW The Russian Direct Investment Fund on Tuesday said comments about the Sputnik V COVID19 vaccine from Brazilian health regulator Anvisa were incorrect and that a decision to delay the vaccines approval could be politically motivated | http://www.reuters.com/places/brazil/article/us-health-coronavirus-russia-brazil/russias-rdif-rejects-brazilian-regulator-anvisas-comments-about-sputnik-v-as-incorrect-idUSKBN2CE1BU | 2021-04-28 |
This query took 6.2281029224396 seconds.